Ju Hyeong Jeon

Title: Ju Hyeong Jeon: Innovator in mRNA Vaccine Technology

Introduction

Ju Hyeong Jeon is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. His innovative work is crucial in the fight against infectious diseases, including the novel coronavirus.

Latest Patents

Ju Hyeong Jeon holds a patent for "Compositions and methods of mRNA vaccines against novel coronavirus infection." This patent describes a ribonucleic acid (RNA) that encodes a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The invention includes at least one non-naturally occurring amino acid mutation, with some embodiments derived from a delta variant. The patent also covers relevant polynucleotides, vectors, cells, compositions, kits, production methods, and methods of use. He has 1 patent to his name.

Career Highlights

Ju Hyeong Jeon is associated with Rnaimmune, Inc., where he continues to advance research in mRNA technology. His work is pivotal in developing effective vaccines that can combat emerging viral threats.

Collaborations

He collaborates with notable colleagues, including Neeti Ananthaswamy and Yong-Sik Bong, who contribute to the innovative research environment at Rnaimmune, Inc.

Conclusion

Ju Hyeong Jeon is a key figure in the advancement of mRNA vaccine technology, with a focus on combating the novel coronavirus. His contributions are vital to public health and the ongoing fight against infectious diseases.